Suppr超能文献

系统性红斑狼疮患者行深板层角膜移植术后疑似角膜基质移植排斥反应。

Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.

机构信息

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong.

出版信息

Eye Contact Lens. 2010 Nov;36(6):371-3. doi: 10.1097/ICL.0b013e3181f6bdc2.

Abstract

PURPOSE

To report a case of presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis (SLE).

METHODS

Deep anterior lamellar keratoplasty was performed using the "bug bubble" technique in the left eye of a 14-year-old patient with keratoconus. Her medical records revealed a history of SLE that was in remission. Immediate postoperative course was uneventful. A best-corrected visual acuity (BCVA) of 20/40 was achieved at the end of 6 months. She was advised to taper off and stop topical corticosteroids by the end of 9 months. The patient presented with a red eye and reduced vision 11 months after surgery. At the time of presentation, the BCVA was 20/200, and ultrasonic central corneal thickness (CCT) was 792 μm in the operated eye. The anterior chamber was found to be quiet, and posterior segment examination was unremarkable. A diagnosis of presumed immune-mediated corneal stromal graft rejection was made. Treatment was started in the form of 1% prednisolone acetate eye drops every hour and 0.5% moxifloxacin hydrochloride eye drops thrice times daily. Hundred milligrams of methylprednisolone in 150 mL of 20% dextrose was administered intravenously.

RESULTS

At the end of 2 weeks, the corneal edema cleared with a resultant CCT of 618 μm, and the BCVA improved to 20/40.

CONCLUSIONS

Deep anterior lamellar keratoplasty does not eliminate the risk of corneal stromal rejection. Our patient had an associated history of SLE, which may necessitate a prolonged topical immunosuppression after corneal transplantation in these cases.

摘要

目的

报告 1 例系统性红斑狼疮(SLE)患者行深板层角膜移植术后疑似角膜基质移植排斥反应。

方法

对 1 例圆锥角膜患者的左眼行深板层角膜移植术,采用“虫泡”技术。其病历显示曾患缓解期 SLE。术后早期无并发症。术后 6 个月最佳矫正视力(BCVA)达 20/40。建议患者在术后 9 个月内逐渐减少并停止局部皮质类固醇的使用。术后 11 个月,患者出现眼红和视力下降。就诊时,BCVA 为 20/200,术眼超声中央角膜厚度(CCT)为 792μm。前房安静,眼底检查未见明显异常。诊断为疑似免疫介导的角膜基质移植排斥反应。治疗开始形式为 1%醋酸泼尼松龙滴眼液每小时 1 次和 0.5%盐酸莫西沙星滴眼液每日 3 次。静脉滴注 150ml 20%葡萄糖溶液中 100mg 甲基泼尼松龙。

结果

2 周后,角膜水肿消退,CCT 为 618μm,BCVA 提高至 20/40。

结论

深板层角膜移植术并不能消除角膜基质排斥反应的风险。我们的患者有相关的 SLE 病史,这可能需要在这些情况下角膜移植后进行长期局部免疫抑制治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验